5-alpha Reductase Inhibitors Adrenergic alpha-Antagonists Age Factors Humans Male Prostatic Hyperplasia/complications/physiopathology Time Factors Treatment Failure Treatment Outcome Urinary Bladder Underactive/complications/*physiopathology Urinary Retention/etiology/*physiopathology Benign prostatic enlargement Benign prostatic hyperplasia Bladder outlet obstruction Delayed prostatectomy Lower urinary tract symptoms

Age Factors Biomarkers Tumor DNA Methylation/genetics Humans Neoplasm Staging Promoter Regions Genetic Proportional Hazards Models Sex Factors Survival Analysis Tumor Suppressor Proteins/*genetics Urinary Bladder Neoplasms/*genetics/*pathology

Age Factors Cystoscopy/*methods Cytodiagnosis Hematuria/*complications/*diagnosis Humans Predictive Value of Tests Sex Factors Smoking Time Factors Urinary Bladder Neoplasms/*complications/diagnosis/urine bladder cancer diagnosis haematuria timeliness urinary bladder neoplasm

Age Factors Aged Aged 80 and over Clinical Decision-Making *Cystectomy/adverse effects/mortality Disease-Free Survival Female Geriatric Assessment Humans Life Expectancy Male Middle Aged Neoplasm Invasiveness Odds Ratio Patient Selection Quality of Life Radiotherapy/adverse effects/mortality Risk Factors Time Factors Treatment Outcome Urinary Bladder Neoplasms/mortality/pathology/*therapy Complications Elderly Mibc Outcome